Former executive at Amedisys Inc
- Key trends and developments in the home healthcare and hospice sector, assessing Amedisys' (NASDAQ: AMED) hospice care offerings
- Amedisys' consolidation and partnership strategy, including its April 2022 Evolution Health acquisition and Contessa's partnerships with Memorial Hermann and Baylor Scott & White Health
- Altering insurance coverage dynamics for hospice care and other reimbursement dynamics in light of evolving regulatory landscape
- Amedisys' competitive positioning vs Kindred (NASDAQ: KND), Encompass and others in product offerings and segment expansion
- Amedisys' 12-18-month growth outlook
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.